Company: MIRM
Filing Date: 2025-08-06
Form Type: 8-K
Source: 0001759425-25-000040
Chunk: 1

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-08-06
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      Press Release dated August 6, 2025                                           
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                            Mirum Pharmaceuticals, Inc.                               
  Date: August 6, 2025      By:                              /s/ Christopher Peetz    
                                                             Christopher Peetz        
                                                             Chief Executive Officer